CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 117 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,930,894 | +39.9% | 129,504 | +2.8% | 0.00% | 0.0% |
| Q2 2023 | $1,379,984 | +336.7% | 126,026 | +24.0% | 0.00% | – |
| Q1 2022 | $316,000 | -11.5% | 101,595 | -3.9% | 0.00% | – |
| Q4 2021 | $357,000 | -8.0% | 105,702 | -0.5% | 0.00% | -100.0% |
| Q3 2021 | $388,000 | -14.5% | 106,187 | +2.0% | 0.00% | 0.0% |
| Q2 2021 | $454,000 | -14.2% | 104,101 | -10.6% | 0.00% | 0.0% |
| Q1 2021 | $529,000 | -24.4% | 116,461 | -4.5% | 0.00% | 0.0% |
| Q4 2020 | $700,000 | -9.9% | 121,941 | +13.6% | 0.00% | 0.0% |
| Q3 2020 | $777,000 | +83.3% | 107,360 | -11.7% | 0.00% | 0.0% |
| Q2 2020 | $424,000 | +236.5% | 121,525 | +43.2% | 0.00% | – |
| Q1 2020 | $126,000 | -24.1% | 84,887 | 0.0% | 0.00% | – |
| Q4 2019 | $166,000 | -61.8% | 84,887 | -0.1% | 0.00% | -100.0% |
| Q3 2019 | $435,000 | -29.0% | 85,005 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $613,000 | -40.7% | 85,580 | +9.9% | 0.00% | -50.0% |
| Q1 2019 | $1,034,000 | +68.7% | 77,843 | -0.1% | 0.00% | +100.0% |
| Q4 2018 | $613,000 | +4.6% | 77,946 | +47.4% | 0.00% | 0.0% |
| Q3 2018 | $586,000 | -21.0% | 52,889 | -4.3% | 0.00% | 0.0% |
| Q2 2018 | $742,000 | – | 55,261 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |